Hellenic Dynamics (HELD) Competitors GBX 0.95 0.00 (0.00%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock HELD vs. CEL, N4P, HLN, BXP, HIK, HCM, INDV, AMYT, APH, and AGYShould you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include Celadon Pharmaceuticals (CEL), N4 Pharma (N4P), Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Alliance Pharma (APH), and Allergy Therapeutics (AGY). These companies are all part of the "drug manufacturers - specialty & generic" industry. Hellenic Dynamics vs. Celadon Pharmaceuticals N4 Pharma Haleon Beximco Pharmaceuticals Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Alliance Pharma Allergy Therapeutics Celadon Pharmaceuticals (LON:CEL) and Hellenic Dynamics (LON:HELD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation. Does the media refer more to CEL or HELD? In the previous week, Celadon Pharmaceuticals had 1 more articles in the media than Hellenic Dynamics. MarketBeat recorded 1 mentions for Celadon Pharmaceuticals and 0 mentions for Hellenic Dynamics. Celadon Pharmaceuticals' average media sentiment score of 0.00 beat Hellenic Dynamics' score of 0.00 indicating that Celadon Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Celadon Pharmaceuticals Neutral Hellenic Dynamics Neutral Do insiders & institutionals have more ownership in CEL or HELD? 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. Comparatively, 0.1% of Hellenic Dynamics shares are held by institutional investors. 65.1% of Celadon Pharmaceuticals shares are held by insiders. Comparatively, 72.9% of Hellenic Dynamics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in CEL or HELD? Celadon Pharmaceuticals received 4 more outperform votes than Hellenic Dynamics when rated by MarketBeat users. CompanyUnderperformOutperformCeladon PharmaceuticalsOutperform Votes4100.00% Underperform VotesNo VotesHellenic DynamicsN/AN/A Which has stronger earnings & valuation, CEL or HELD? Celadon Pharmaceuticals has higher revenue and earnings than Hellenic Dynamics. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than Hellenic Dynamics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeladon Pharmaceuticals£123.38K30.42-£4.97M-£7.98-0.77Hellenic DynamicsN/AN/A-£5.22M-£3.55-0.27 Is CEL or HELD more profitable? Hellenic Dynamics has a net margin of 0.00% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Celadon Pharmaceuticals' return on equity of -187.26% beat Hellenic Dynamics' return on equity.Company Net Margins Return on Equity Return on Assets Celadon Pharmaceuticals-4,024.62% -187.26% -34.40% Hellenic Dynamics N/A -364.21%N/A SummaryCeladon Pharmaceuticals beats Hellenic Dynamics on 7 of the 12 factors compared between the two stocks. Remove Ads Get Hellenic Dynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HELD vs. The Competition Export to ExcelMetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£1.40M£2.28B£5.64B£2.56BDividend YieldN/A2.92%5.34%4.95%P/E Ratio-0.274.3223.63138.55Price / SalesN/A489.75370.10277,004.67Price / CashN/A10.2538.1727.96Price / Book0.626.296.744.51Net Income-£5.22M£20.70B£3.20B£5.77B7 Day PerformanceN/A-2.99%-5.62%-0.62%1 Month PerformanceN/A-3.38%-0.37%5.13%1 Year Performance-62.75%92.61%7.73%31.04% Hellenic Dynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HELDHellenic DynamicsN/AGBX 0.95flatN/AN/A£1.40MN/A-0.27N/ACELCeladon PharmaceuticalsN/AGBX 8-15.8%N/A-92.7%£4.91M£123,381.65-1.002,780News CoverageGap DownN4PN4 PharmaN/AGBX 0.50+5.3%N/A-37.7%£2.15M£8,841.37-1.445Gap DownHLNHaleon0.568 of 5 starsGBX 382.50+0.1%GBX 420+9.8%+17.6%£34.52B£11.07B32.1725,408High Trading VolumeBXPBeximco PharmaceuticalsN/AGBX 38.25-0.6%N/A-1.0%£26.07B£7.08T4.105,500Negative NewsHIKHikma Pharmaceuticals3.5226 of 5 starsGBX 1,997-0.6%GBX 2,436.67+22.0%+1.6%£5.54B£3.74B19.609,100High Trading VolumeHCMHUTCHMEDN/AGBX 235+7.8%N/A-13.3%£2.55B£771.01M-59.981,760High Trading VolumeINDVIndivior2.1606 of 5 starsGBX 757.50+1.6%GBX 1,650+117.8%-58.0%£1.18B£1.40B-628.081,000High Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAPHAlliance Pharma1.774 of 5 starsGBX 64.30+0.3%GBX 6,250+9,620.1%+61.5%£348.15M£183.50M-10.3691,000AGYAllergy TherapeuticsN/AGBX 6.27-3.6%N/A+110.0%£308.08M£72.18M-6.04612Earnings ReportNews Coverage Remove Ads Related Companies and Tools Related Companies Celadon Pharmaceuticals Competitors N4 Pharma Competitors Haleon Competitors Beximco Pharmaceuticals Competitors Hikma Pharmaceuticals Competitors HUTCHMED Competitors Indivior Competitors Amryt Pharma Competitors Alliance Pharma Competitors Allergy Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HELD) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hellenic Dynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hellenic Dynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HELD Stock Free HELD Stock Alerts